Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke

NCT05363397 is registered in ClinicalTrials.gov with The Florey Institute of Neuroscience and Mental Health as lead sponsor.

NCT NCT05363397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05363397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Lead sponsor
The Florey Institute of Neuroscience and Mental Health
Phase
Phase 2
Overall status
Recruiting
Start date
September 27, 2023
Completion date
May 1, 2026
Enrollment
80 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke